| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |